IMMUNIC, INC.
Developing oral small molecule therapies for chronic inflammatory and autoimmune diseases.
IMUX | US
Overview
Corporate Details
- ISIN(s):
- US4525EP1011 (+1 more)
- LEI:
- 549300R5T12FW5MEQB20
- Country:
- United States of America
- Address:
- 1200 AVENUE OF THE AMERICAS, 10036 NEW YORK
- Website:
- https://imux.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Immunic, Inc. is a clinical-stage biotechnology company developing a pipeline of selective, orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. The company focuses on creating differentiated programs to address unmet patient needs in conditions such as multiple sclerosis and celiac disease. Its mission is to develop high-quality, oral treatment options with comprehensive therapeutic efficacy and favorable safety and tolerability profiles, aiming to elevate the standard of care for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-13 12:30 |
Earnings Release
Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corpora…
|
English | 22.9 KB | ||
| 2025-10-29 11:30 |
Regulatory News Service
Immunic to Participate in Industry and Investor Conferences in November
|
English | 9.7 KB | ||
| 2025-10-01 12:30 |
Regulatory News Service
Immunic to Participate in Scientific and Investor Conferences in October
|
English | 14.9 KB | ||
| 2025-09-25 12:30 |
Regulatory News Service
Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS…
|
English | 23.6 KB | ||
| 2025-09-09 12:30 |
Regulatory News Service
Immunic Receives Notice of Allowance for United States Patent Protecting Vidofl…
|
English | 13.9 KB | ||
| 2025-09-04 12:30 |
Regulatory News Service
Immunic to Participate in Investor and Scientific Conferences in September
|
English | 15.6 KB | ||
| 2025-08-07 12:30 |
Earnings Release
Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corpor…
|
English | 23.5 KB | ||
| 2025-06-24 12:30 |
Regulatory News Service
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 …
|
English | 15.2 KB | ||
| 2025-06-05 12:30 |
Legal Proceedings Report
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Re…
|
English | 18.3 KB | ||
| 2025-06-02 12:30 |
Regulatory News Service
Immunic to Participate in Investor, Scientific and Industry Conferences in June
|
English | 13.9 KB |
Automate Your Workflow. Get a real-time feed of all IMMUNIC, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IMMUNIC, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IMMUNIC, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
